1. Home
  2. DAKT vs GOSS Comparison

DAKT vs GOSS Comparison

Compare DAKT & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Daktronics Inc.

DAKT

Daktronics Inc.

HOLD

Current Price

$20.49

Market Cap

872.1M

Sector

Industrials

ML Signal

HOLD

Logo Gossamer Bio Inc.

GOSS

Gossamer Bio Inc.

HOLD

Current Price

$2.54

Market Cap

796.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAKT
GOSS
Founded
1968
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
872.1M
796.2M
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
DAKT
GOSS
Price
$20.49
$2.54
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
6
Target Price
$26.00
$8.60
AVG Volume (30 Days)
612.6K
4.5M
Earning Date
12-10-2025
11-05-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.15
N/A
Revenue
$770,283,000.00
$44,051,000.00
Revenue This Year
$13.76
N/A
Revenue Next Year
$7.35
$6.41
P/E Ratio
$138.94
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.24
$0.76
52 Week High
$24.38
$3.87

Technical Indicators

Market Signals
Indicator
DAKT
GOSS
Relative Strength Index (RSI) 63.49 32.83
Support Level $19.48 $3.04
Resistance Level $19.08 $3.87
Average True Range (ATR) 0.64 0.28
MACD 0.17 -0.13
Stochastic Oscillator 96.72 0.74

Price Performance

Historical Comparison
DAKT
GOSS

About DAKT Daktronics Inc.

Daktronics Inc designs and manufactures electronic scoreboards, programmable display systems, and large-screen video displays for sporting, commercial, and transportation applications. It is engaged in a full range of activities: marketing and sales, engineering and product design and development, manufacturing, technical contracting, professional services, and customer service and support. The company offers a complete line of products, from small scoreboards and electronic displays to large multimillion-dollar video display systems as well as related control, timing, and sound systems. The company has five reportable segments: Commercial, Live Events, High School Park and Recreation, Transportation, and International. The company makes the majority of its revenue from Live events.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Share on Social Networks: